Clal Industries & Investments Ltd insider trades: Biocancell Therapeutics (BICL) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Clal Industries & Investments Ltd reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jan 24, 2012 | BICL | ↑ Buy | 8,199,400 | $0.26 | $2.1M | Direct | Mar 7, 2012 (43d) |
| May 19, 2005 | FNDT | ↑ Buy | 34,890 | $10.01 | $349K | Direct | May 24, 2005 (5d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Clal Industries & Investments Ltd's insider trades
Clal Industries & Investments Ltd is a 10% owner of Biocancell Therapeutics (BICL). Since May 19, 2005, it has reported 2 open-market purchases worth $2.5M and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Its filings also include other transactions (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BICL insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.